Suppr超能文献

监测凝血酶生成:是否需要添加玉米胰蛋白酶抑制剂?

Monitoring thrombin generation: is addition of corn trypsin inhibitor needed?

机构信息

Department of Internal Medicine, Laboratory for Clinical Thrombosis and Haemostasis, Cardiovascular Research Institute Maastricht, Maastricht University, P.O. Box 616, UNS50/Box8, 6200 MD Maastricht, The Netherlands.

出版信息

Thromb Haemost. 2009 Jun;101(6):1156-62.

Abstract

Thrombin generation monitoring has the potential to be used as a clinical diagnostic tool in the near future. However, robust preanalytical conditions may be required, and one factor that has been reported is in-vitro contact activation that might influence in-vitro measurements of thrombin generation and thereby act as an unpredictable pre-analytical variable. The aim of the current study was to investigate the influence of contact activation and the necessity of corn trypsin inhibitor (CTI) to abolish contact activation in thrombin generation measurements at low tissue factor (TF) concentrations. Thrombin generation was performed using the calibrated automated thrombinoscopy (CAT), thereby determining the endogenous thrombin potential (ETP), peak height, and the lag time, in plasma obtained from healthy volunteers. Addition of CTI after plasma preparation had no significant influence on thrombin generation triggered with 0.5 pM TF or higher, as demonstrated by unaltered ETP and lag time values between analyses with and without CTI. Addition of CTI before blood collection reduced thrombin generation triggered with 0.5 pM TF: both the ETP and peak height were significantly reduced compared to no CTI addition. In contrast, thrombin generation remained unaltered at a 1 pM TF trigger or above. This study demonstrates that addition of CTI after plasma separation is not necessary when triggering with TF concentrations of 0.5 pM and higher. Furthermore, it was demonstrated that it is not needed to pre-fill blood collecting tubes with CTI when measuring thrombin generation at TF concentrations of >/=1 pM.

摘要

凝血酶生成监测有可能在不久的将来成为一种临床诊断工具。然而,可能需要严格的分析前条件,据报道,一个因素是体外接触激活,可能会影响凝血酶生成的体外测量,并因此作为一个不可预测的分析前变量。本研究旨在探讨接触激活的影响,以及在低组织因子 (TF) 浓度下进行凝血酶生成测量时需要玉米胰蛋白酶抑制剂 (CTI) 来消除接触激活的必要性。使用校准自动凝血酶检测法 (CAT) 进行凝血酶生成,从而确定来自健康志愿者的血浆中的内源性凝血酶潜能 (ETP)、峰值高度和滞后时间。在血浆制备后添加 CTI 对用 0.5 pM TF 或更高浓度触发的凝血酶生成没有显著影响,因为在有和没有 CTI 的分析中,ETP 和滞后时间值没有改变。在采血前添加 CTI 会减少用 0.5 pM TF 触发的凝血酶生成:与没有添加 CTI 相比,ETP 和峰值高度均显著降低。相比之下,当用 1 pM TF 或更高浓度触发时,凝血酶生成保持不变。本研究表明,当用 0.5 pM 及更高浓度的 TF 触发时,在分离血浆后添加 CTI 是不必要的。此外,当用 >/=1 pM 的 TF 浓度测量凝血酶生成时,不需要在采血管中预先填充 CTI。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验